Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Preliminary analysis of a phase 2b, randomized, active-control study of flonoltinib maleate (FM) vs. ruxolitinib in intermediate-2 or high-risk myelofibrosis patients

Blood (2025) 146 (Supplement 1): 908.

https://doi.org/10.1182/blood-2025-908

Published: 2025

Journal Articles

Adult Acute Myeloid Leukemia with fus::ERG fusion: A national, retrospective, multi-center study

Xiaoxia Hu, Yunxiang Zhang, Jianfeng Li, Jingtao Huang, Shaowei Qiu, Anli Lai, Jia Chen, Xiao-Dong Mo, Huafeng Wang, Yanmin Zhao, Xiaoyu Zhu, Yang Cao, Ran Zhang, Weijie Cao, Yue Lu, Fang Zhou, Xiangqin Weng, Yongmei Zhu

Blood (2025) 146 (Supplement 1): 1698.

https://doi.org/10.1182/blood-2025-1698

Published: 2025

Journal Articles

Efficacy and safety of iptacopan in paroxysmal nocturnal hemoglobinuria (PNH): A real-world study of 35 patients from anhui, China

Ziwei Zhou, Fengbo Jin, Li Ye, Xin Sun, Jing Wang, Xiaoxing Sun, Yiming Zhao, Yan Dai, Lingsu Gao, Binbin Jiang, Qichuan Jin, Yuehong Li, Qinhua Liu, Qinqin Zhao, Shengneng Tao, Xiaoyu Zhu

Blood (2025) 146 (Supplement 1): 6538.

https://doi.org/10.1182/blood-2025-6538

Published: 2025

Journal Articles

Evaluating the efficacy of umbilical cord blood transplantation in TP53-mutated AML/MDS: Encouraging survival outcomes

Kepeng Yang, Xiaoyu Zhu, Baolin Tang

Blood (2025) 146 (Supplement 1): 7821.

https://doi.org/10.1182/blood-2025-7821

Published: 2025

Journal Articles

Results of a registrational Phase 2 study of lisaftoclax monotherapy for treatment of patients (pts) with Relapsed/Refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who had failed Bruton's tyrosine kinase inhibitors (BTKis)

Blood (2025) 146 (Supplement 1): 88.

https://doi.org/10.1182/blood-2025-88

Published: 2025

Journal Articles

CTD402, allogeneic anti-CD7 CAR t-cell, in relapsed or refractory (R/R) t-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (T-ALL/LBL) - report of clinical outcomes at the recommended phase 2 dose (RP2D)

Blood (2025) 146 (Supplement 1): 1042.

https://doi.org/10.1182/blood-2025-1042

Published: 2025

Journal Articles

TDI01 in the treatment of moderate to severe chronic graft-versus-host disease: Updated results from a multicenter, OPEN-label phase IB/II study (An Update)

Xiaojun Huang, Xiao-Dong Mo, Xuejun Zhang, Rong Guo, Er-Lie Jiang, Jiejing Qian, Xiaoyu Zhu, Jia Wei, Shun-Qing Wang, Zhongming Zhang, Zhuogang Liu, Yuxian Huang, Zhiguo Wang, Xiaoyuan Dong, Hai Yi, Ying Li

Blood (2025) 146 (Supplement 1): 4229.

https://doi.org/10.1182/blood-2025-4229

Published: 2025

Journal Articles

CD7-targeted universal CAR T-cell therapy in relapsed or refractory (R/R) acute myeloid leukemia (AML): Clinical results from CTD401/402 studies

Yong-xian Hu, Xiaoyu Zhu, Heng Mei, Ying Wang, Yali Zhou, Kangqi Bian, Maria del Rosario, Eileen McNulty, Ming Gao, Lu Han, Wengang Ge, Jan Davidson-Moncada, Jiangtao Ren, He Huang

Blood (2025) 146 (Supplement 1): 816.

https://doi.org/10.1182/blood-2025-816

Published: 2025

Journal Articles

Stratos: An AI-driven biomarker signature for prognostic risk stratification in transplant-associated thrombotic microangiopathy - a nationwide, multicenter study

Blood (2025) 146 (Supplement 1): 120.

https://doi.org/10.1182/blood-2025-120

Published: 2025

Journal Articles

Phase 1/2, multi-center, open-label clinical study to evaluate the safety, pharmacokinetics, and efficacy of zefamenib in patients with relapsed/refractory acute leukemia

Blood (2025) 146 (Supplement 1): 5209.

https://doi.org/10.1182/blood-2025-5209

Published: 2025

Journal Articles

Distinct prognosis and transplant timing in core-binding factor Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 5297.

https://doi.org/10.1182/blood-2025-5297

Published: 2025

Journal Articles

Insights from a multicenter study on the outcomes of liver abscess after allogeneic hematopoietic stem cell transplantation

Blood (2025) 146 (Supplement 1): 4267.

https://doi.org/10.1182/blood-2025-4267

Published: 2025

Journal Articles

CTA311, a universal anti-CD19 CAR t-cell therapy with improved persistence for patients with CD19+ relapsed/ refractory (R/R) b-cell acute lymphoblastic leukemia (B-ALL)

Guangyu Sun, Heng Mei, Anyou Wang, Tianzhong Pan, Yali Zhou, Gong Chen, Jiuqin Zeng, Kangqi Bian, Jan Davidson-Moncada, Bo Pei, Lu Han, Jiangtao Ren, Xiaoyu Zhu

Blood (2025) 146 (Supplement 1): 5920.

https://doi.org/10.1182/blood-2025-5920

Published: 2025

Journal Articles

Long-term outcomes of double-negative T cell therapy in AML patients with relapse post allo-HSCT

Dongyao Wang, Shijuan Peng, Yining Wang, Xiaoman Wang, Guangyu Sun, Xiaoyu Zhu

Blood (2025) 146 (Supplement 1): 5910.

https://doi.org/10.1182/blood-2025-5910

Published: 2025

Journal Articles

Changing Donor Was Critical for the Successful Salvage Second Transplantation for Graft Failure after the First Allogeneic Stem Cell Transplantation: A Chinese Multicenter Retrospective Study

Blood (2024) 144 (Supplement 1): 2109.

https://doi.org/10.1182/blood-2024-205561

Published: 2024

Journal Articles

Efficacy and Safety of Hetrombopag in Promoting Platelet Engraftment after Allogeneic Stem Cell Transplantation: A Prospective, Single-Arm Clinical Trail

Aijie Huang, Guangyu Sun, Baolin Tang, Yongsheng Han, Xiang Wan, Wen Yao, Kaidi Song, Yaxin Cheng, Meijuan Tu, Bingbing Yan, Tianzhong Pan, Yue Wu, Dongyao Wang, Xiaoyu Zhu

Blood (2024) 144 (Supplement 1): 3504.

https://doi.org/10.1182/blood-2024-202427

Published: 2024

Journal Articles

Effective Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease with Human Induced Pluripotent Stem Cell Derived Mesenchymal Stromal Cells (iMSC) in a Clinical Setting

Guangyu Sun, Jie Chen, Baolin Tang, Yongsheng Han, Xiang Wan, Yaxin Cheng, Qian Fan, Ziwei Zhou, Yanqiu Li, Ying Zhang, Xiaoyu Zhu

Blood (2024) 144 (Supplement 1): 2138.

https://doi.org/10.1182/blood-2024-204784

Published: 2024

Journal Articles

Invasive Fungal Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in China: A Multicenter Epidemiological Study (CAESAR 2.0)

Chuan Li, Danping Zhu, Jia Chen, Xiaoyu Zhu, Nainong Li, Weijie Cao, Zhongming Zhang, Yehui Tan, Xiaoxia Hu, Hailong Yuan, Xiaosheng Fang, Yue Yin, Hongtao Wang, Nan Li, Xiao Jun Huang, Yuqian Sun

Blood (2024) 144 (Supplement 1): 2133.

https://doi.org/10.1182/blood-2024-202020

Published: 2024

Journal Articles

Venetoclax Enhances Human Γδt Cells Anti-Leukemia Immunity through Metabolic Reprogramming

Chen Xingchi, Guangyu Sun, Yinqiang Sui, Weiwei Ma, Yonghui Zhang, Xiaoyu Zhu

Blood (2024) 144 (Supplement 1): 2059.

https://doi.org/10.1182/blood-2024-202223

Published: 2024

Journal Articles

A First-in-Human Phase 1/2 Study of the Menin-KMT2A(MLL1) Inhibitor BN104 in Adult Patients with Relapsed or Refractory Acute Leukemia

Blood (2024) 144 (Supplement 1): 2879.

https://doi.org/10.1182/blood-2024-198959

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Preliminary analysis of a phase 2b, randomized, active-control study of flonoltinib maleate (FM) vs. ruxolitinib in intermediate-2 or high-risk myelofibrosis patients

Adult Acute Myeloid Leukemia with fus::ERG fusion: A national, retrospective, multi-center study

Efficacy and safety of iptacopan in paroxysmal nocturnal hemoglobinuria (PNH): A real-world study of 35 patients from anhui, China

Evaluating the efficacy of umbilical cord blood transplantation in TP53-mutated AML/MDS: Encouraging survival outcomes

Results of a registrational Phase 2 study of lisaftoclax monotherapy for treatment of patients (pts) with Relapsed/Refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who had failed Bruton's tyrosine kinase inhibitors (BTKis)

CTD402, allogeneic anti-CD7 CAR t-cell, in relapsed or refractory (R/R) t-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (T-ALL/LBL) - report of clinical outcomes at the recommended phase 2 dose (RP2D)

TDI01 in the treatment of moderate to severe chronic graft-versus-host disease: Updated results from a multicenter, OPEN-label phase IB/II study (An Update)

CD7-targeted universal CAR T-cell therapy in relapsed or refractory (R/R) acute myeloid leukemia (AML): Clinical results from CTD401/402 studies

Stratos: An AI-driven biomarker signature for prognostic risk stratification in transplant-associated thrombotic microangiopathy - a nationwide, multicenter study

Phase 1/2, multi-center, open-label clinical study to evaluate the safety, pharmacokinetics, and efficacy of zefamenib in patients with relapsed/refractory acute leukemia

Distinct prognosis and transplant timing in core-binding factor Acute Myeloid Leukemia

Insights from a multicenter study on the outcomes of liver abscess after allogeneic hematopoietic stem cell transplantation

CTA311, a universal anti-CD19 CAR t-cell therapy with improved persistence for patients with CD19+ relapsed/ refractory (R/R) b-cell acute lymphoblastic leukemia (B-ALL)

Long-term outcomes of double-negative T cell therapy in AML patients with relapse post allo-HSCT

Changing Donor Was Critical for the Successful Salvage Second Transplantation for Graft Failure after the First Allogeneic Stem Cell Transplantation: A Chinese Multicenter Retrospective Study

Efficacy and Safety of Hetrombopag in Promoting Platelet Engraftment after Allogeneic Stem Cell Transplantation: A Prospective, Single-Arm Clinical Trail

Effective Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease with Human Induced Pluripotent Stem Cell Derived Mesenchymal Stromal Cells (iMSC) in a Clinical Setting

Invasive Fungal Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in China: A Multicenter Epidemiological Study (CAESAR 2.0)

Venetoclax Enhances Human Γδt Cells Anti-Leukemia Immunity through Metabolic Reprogramming

A First-in-Human Phase 1/2 Study of the Menin-KMT2A(MLL1) Inhibitor BN104 in Adult Patients with Relapsed or Refractory Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only